ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.11254+2T>C (rs199565715)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000155005 SCV000204687 uncertain significance not specified 2014-05-28 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The 10741+2T>C vari ant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 0.4% (17/3882) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs1995 65715). This variant occurs in the invariant region (+/- 1,2) of the splice cons ensus sequence. Splice and other truncating variants in TTN are strongly associa ted with DCM, particularly if they are located in exons encoding for the A-band region of the protein (Herman 2012, Pugh 2014). Variants in the I-band (where th e 10741+2T>C variant is located) occur at greater frequency in controls than in patients (Pugh 2014). This decreases but does not rule out that this variant ha s a role in disease. In summary, while the clinical significance of the 10741+2T >C variant is uncertain, these data suggest that it is more likely to be benign.
GeneDx RCV000155005 SCV000237027 uncertain significance not specified 2016-06-02 criteria provided, single submitter clinical testing The c.10741+2 T>C variant of uncertain significance was identified in one individual from a cohort of 172 women diagnosed with peripartum cardiomoypathy (Ware et al., 2016). Nevertheless, this variant has been observed in a relatively high frequency among individuals in the general population. The 1000 Genomes Project, NHLBI Exome Sequencing Project, and the Exome Aggregation Consortium report that c.10741+2 T>C was observed in 0.23-0.44% of alleles from individuals of African American background, indicating it may be a rare benign variant in this population. Although the c.10741+2 T>C variant may destroy the canonical splice donor site of intron 44, a deleterious splicing effect is less likely given the lack of evolutionary conservation at this nucleotide position. Moreover, the c.10741+2 T>C variant resides in an inferred transcript that includes all possible supported in-frame coding exons. The expression pattern of this transcript is unknown. This variant maps to deep intronic regions in the major cardiac titin isoforms (N2BA; NM_001256850 and N2-B; NM_003319). Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign.
Invitae RCV000713962 SCV000261793 likely benign not provided 2018-03-29 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000155005 SCV000704242 likely benign not specified 2017-01-27 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000155005 SCV000844614 benign not specified 2019-11-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.